GLUE Stock-Based Compensation
Monte Rosa Therapeutics Inc · Stock-Based Compensation
GLUE Stock-Based Compensation
Latest reported$20.59Mperiod ending
GLUE Stock-Based Comp ($0.00 → $20.59M)
Annual stock-based compensation
High-resolution chart · PNG
GLUE stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 18,865,000 | |
| 18,126,000 | |
| 16,669,000 | |
| 11,664,000 | |
| 5,200,000 | |
| 354,000 | |
| 0 |